potassium iodide has been researched along with Basedow Disease in 70 studies
Potassium Iodide: An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
potassium iodide : A metal iodide salt with a K(+) counterion. It is a scavenger of hydroxyl radicals.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effectiveness of potassium iodide (KI) (100 mg/day) was evaluated in 504 untreated patients with Graves' hyperthyroidism (GD)." | 8.12 | Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment. ( Bandai, S; Fujikawa, M; Ikenoue, H; Kitazono, T; Okamura, K; Sato, K, 2022) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 7.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| "Potassium iodide (KI) has traditionally been used to reduce gland vascularity and diminish blood loss in patients undergoing thyroidectomy for Graves disease (GD)." | 7.79 | Is potassium iodide solution necessary before total thyroidectomy for Graves disease? ( Baker, A; Broome, JT; Shinall, MC; Solorzano, CC, 2013) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 7.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 6.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 5.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "Permanent vocal cord paresis and permanent hypoparathyroidism were similar in both groups." | 5.56 | Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center. ( Fendrich, V; Kußmann, J; Lindner, K, 2020) |
| "The effect of radioiodine therapy in Graves' disease is gradual in onset and the subjects continue to be hyperthyroid for several weeks after such therapy." | 5.29 | Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. ( Bagchi, N; Bazzi, MN, 1993) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 5.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 5.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 5.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| "Combined treatment with anti-thyroid drugs (ATDs) and potassium iodide (KI) has been used only for severe thyrotoxicosis or as a pretreatment before urgent thyroidectomy in patients with Graves' disease." | 5.14 | Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. ( Amino, N; Fukata, S; Ito, M; Kubota, S; Kudo, T; Miyauchi, A; Nishihara, E; Sasaki, I; Takata, K, 2010) |
| "The effectiveness of potassium iodide (KI) (100 mg/day) was evaluated in 504 untreated patients with Graves' hyperthyroidism (GD)." | 4.12 | Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment. ( Bandai, S; Fujikawa, M; Ikenoue, H; Kitazono, T; Okamura, K; Sato, K, 2022) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 3.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| "Potassium iodide (KI) has traditionally been used to reduce gland vascularity and diminish blood loss in patients undergoing thyroidectomy for Graves disease (GD)." | 3.79 | Is potassium iodide solution necessary before total thyroidectomy for Graves disease? ( Baker, A; Broome, JT; Shinall, MC; Solorzano, CC, 2013) |
| "We report a newborn female with neonatal hyperthyroidism, born to a mother with Graves disease treated with potassium iodide and carbimazole." | 3.67 | [Transient neonatal hyperthyroidism in the child of a treated hyperthyroid mother. Subsequent appearance of sexual precocity]. ( Alvarez, J; Cortabarría, C; Doménech, E; González, C; Méndez, A; Moya, M; Rodríguez-Luis, JC; Santisteban, M, 1985) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 3.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 2.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "Graves disease is the most common cause of persistent hyperthyroidism in adults." | 2.52 | Management of Graves Disease: A Review. ( Burch, HB; Cooper, DS, 2015) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 1.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "She underwent right mastectomy for breast cancer and had received aromatase inhibitor and denosumab therapy for 5 years." | 1.56 | Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab. ( Kushima, C; Nakazato, M; Uchida, T; Yamaguchi, H; Yonekawa, T, 2020) |
| "Permanent vocal cord paresis and permanent hypoparathyroidism were similar in both groups." | 1.56 | Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center. ( Fendrich, V; Kußmann, J; Lindner, K, 2020) |
| "There are only a few reports on Graves' disease induced by ICIs." | 1.56 | New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report. ( Emoto, N; Fujimori, S; Okajima, F; Onda, T; Sugihara, H; Yamada, H, 2020) |
| "Thyroid storm is a life-threatening condition that is generally considered to be a contradiction to surgical intervention." | 1.42 | Thyroidectomy in a patient with thyroid storm: report of a case. ( Ishiguro, K; Suda, T; Uchida, N, 2015) |
| "Treatment with propylthiouracil, iodide potassium (KI), and prednisolone (PSL) was started, which resulted in improvement of the general condition." | 1.40 | Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. ( Arao, T; Kurozumi, A; Mori, H; Narisawa, M; Okada, Y; Tanaka, Y; Torimoto, K; Yamamoto, S, 2014) |
| "In particular, cardiac failure was observed in the second fetus." | 1.39 | Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy. ( Ikenoue, S; Ishii, T; Kadohira, I; Kasuga, Y; Matsumoto, T; Minegishi, K; Miyakoshi, K; Momotani, N; Saisho, Y; Sato, S; Yoshimura, Y, 2013) |
| "The effect of radioiodine therapy in Graves' disease is gradual in onset and the subjects continue to be hyperthyroid for several weeks after such therapy." | 1.29 | Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. ( Bagchi, N; Bazzi, MN, 1993) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 1.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| " One hundred and eighty-six were given a dose adjusted for thyroid size and radioactive iodine uptake (Protocol 1), and a second group received the same dosage followed by antithyroid drug therapy plus potassium iodide for 15 days (Protocol 2)." | 1.28 | Comparison of RA 131I treatment protocols for Graves' disease. ( DeGroot, LJ; Mangklabruks, A; McCormick, M, 1990) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 1.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| "Pre-treatment with potassium iodide reduced serum T4 to normal or subnormal in all patients." | 1.27 | The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens. ( Browning, MC; Feely, J; Forrest, AL; Gunn, A; Hamilton, WF; Isles, TE; Peden, NR, 1985) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 1.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| "1." | 1.25 | Thyroid failure after potassium iodide treatment of diffuse toxic goiter. ( Maloof, F; Wood, LC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (41.43) | 18.7374 |
| 1990's | 5 (7.14) | 18.2507 |
| 2000's | 1 (1.43) | 29.6817 |
| 2010's | 20 (28.57) | 24.3611 |
| 2020's | 15 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Okamura, K | 5 |
| Sato, K | 4 |
| Fujikawa, M | 4 |
| Bandai, S | 4 |
| Ikenoue, H | 3 |
| Kitazono, T | 4 |
| Fukahori, K | 1 |
| Sawano, K | 1 |
| Yoshida, H | 1 |
| Nagasaki, K | 1 |
| Mikura, K | 1 |
| Yoshimura Noh, J | 2 |
| Watanabe, N | 4 |
| Aida, A | 1 |
| Yoshimura, R | 1 |
| Kinoshita, A | 1 |
| Suzuki, A | 1 |
| Suzuki, N | 4 |
| Fukushita, M | 1 |
| Matsumoto, M | 5 |
| Yoshihara, A | 4 |
| Sugino, K | 5 |
| Ito, K | 6 |
| Uchida, T | 4 |
| Yamaguchi, H | 1 |
| Kushima, C | 1 |
| Yonekawa, T | 1 |
| Nakazato, M | 1 |
| Noh, JY | 3 |
| Kunii, Y | 4 |
| Suzuki, M | 4 |
| Hiruma, M | 2 |
| Morisaki, M | 2 |
| Kawaguchi, A | 2 |
| Park, BD | 1 |
| Lyn-Kew, K | 1 |
| Granchelli, A | 1 |
| Mehta, A | 1 |
| Sugisawa, C | 1 |
| Hoshiyama, A | 1 |
| Ohye, H | 2 |
| Lindner, K | 1 |
| Kußmann, J | 1 |
| Fendrich, V | 1 |
| Nishio, R | 1 |
| Suzuki, L | 1 |
| Onose, H | 1 |
| Goto, H | 3 |
| Yamada, E | 1 |
| Satoh, H | 1 |
| Watada, H | 3 |
| Yamada, H | 2 |
| Okajima, F | 1 |
| Onda, T | 1 |
| Fujimori, S | 1 |
| Emoto, N | 1 |
| Sugihara, H | 1 |
| Kamijo, K | 1 |
| Barranquero, AG | 1 |
| Muñoz de Nova, JL | 1 |
| Gómez-Ramírez, J | 1 |
| Valdés de Anca, Á | 1 |
| Porrero, B | 1 |
| Blanco Terés, L | 1 |
| Corral, S | 1 |
| Martín-Pérez, E | 1 |
| Washio, K | 1 |
| Uenaka, M | 1 |
| Tanimura, K | 1 |
| Deguchi, M | 1 |
| Nishida, K | 1 |
| Fujioka, K | 1 |
| Elaraj, DM | 1 |
| Fahey, TJ | 1 |
| Randle, RW | 1 |
| Bates, MF | 1 |
| Long, KL | 1 |
| Pitt, SC | 1 |
| Schneider, DF | 1 |
| Sippel, RS | 1 |
| Honda, A | 2 |
| Komiya, K | 2 |
| Takeno, K | 2 |
| Sato, J | 2 |
| Suzuki, R | 1 |
| Himuro, M | 1 |
| Shreyamsa, M | 1 |
| Mouli, VS | 1 |
| Singh, KR | 1 |
| Ramakant, P | 1 |
| Mishra, A | 1 |
| Shinall, MC | 1 |
| Broome, JT | 1 |
| Baker, A | 1 |
| Solorzano, CC | 1 |
| Matsumoto, T | 1 |
| Miyakoshi, K | 1 |
| Saisho, Y | 1 |
| Ishii, T | 1 |
| Ikenoue, S | 1 |
| Kasuga, Y | 1 |
| Kadohira, I | 1 |
| Sato, S | 3 |
| Momotani, N | 1 |
| Minegishi, K | 1 |
| Yoshimura, Y | 1 |
| Uchida, N | 1 |
| Suda, T | 1 |
| Ishiguro, K | 1 |
| Torimoto, K | 1 |
| Okada, Y | 1 |
| Arao, T | 1 |
| Mori, H | 1 |
| Yamamoto, S | 1 |
| Narisawa, M | 1 |
| Kurozumi, A | 1 |
| Tanaka, Y | 1 |
| Kasai, T | 1 |
| Abe, H | 1 |
| Shigihara, N | 1 |
| Mita, T | 1 |
| Kanazawa, A | 1 |
| Fujitani, Y | 1 |
| Bisschop, PH | 1 |
| van Trotsenburg, AS | 1 |
| Yasuda, S | 1 |
| Mukasa, K | 2 |
| Nagataki, S | 1 |
| Taniyama, M | 1 |
| Korsholm, AS | 1 |
| Ebbehøj, E | 1 |
| Richelsen, B | 1 |
| Kameda, T | 1 |
| Iwaku, K | 1 |
| Kobayashi, S | 1 |
| Burch, HB | 1 |
| Cooper, DS | 1 |
| Whalen, G | 1 |
| Sullivan, M | 1 |
| Maranda, L | 1 |
| Quinlan, R | 1 |
| Larkin, A | 1 |
| Jha, CK | 1 |
| Bichoo, RA | 1 |
| Yadav, SK | 1 |
| Yabuta, T | 1 |
| Ito, Y | 1 |
| Hirokawa, M | 1 |
| Fukushima, M | 1 |
| Inoue, H | 1 |
| Tomoda, C | 1 |
| Higashiyama, T | 1 |
| Kihara, M | 1 |
| Uruno, T | 1 |
| Takamura, Y | 1 |
| Kobayashi, K | 1 |
| Miya, A | 1 |
| Matsuzuka, F | 1 |
| Miyauchi, A | 2 |
| Takata, K | 1 |
| Amino, N | 1 |
| Kubota, S | 1 |
| Sasaki, I | 1 |
| Nishihara, E | 1 |
| Kudo, T | 1 |
| Ito, M | 1 |
| Fukata, S | 1 |
| Hegedüs, L | 1 |
| Bish, LT | 1 |
| Bavaria, JE | 1 |
| Augoustides, J | 1 |
| Yoshinari, M | 1 |
| Inoue, K | 1 |
| Nakashima, T | 1 |
| Shiroozu, A | 1 |
| Nishitani, H | 1 |
| Omae, T | 1 |
| Torisu, M | 1 |
| Noguchi, S | 1 |
| Houlbert, D | 1 |
| Wassef, M | 1 |
| Lajeunie, E | 1 |
| Dahan, R | 1 |
| Tran ba Huy, P | 1 |
| Caporal, R | 1 |
| Segrestaa, JM | 1 |
| Ross, DS | 1 |
| Daniels, GH | 1 |
| De Stefano, P | 1 |
| Maloof, F | 3 |
| Ridgway, EC | 1 |
| Feek, CM | 1 |
| Sawers, JS | 1 |
| Irvine, WJ | 1 |
| Beckett, GJ | 1 |
| Ratcliffe, WA | 1 |
| Toft, AD | 1 |
| Emerson, CH | 1 |
| El-Zaheri, MM | 1 |
| Feely, J | 2 |
| Contegiacomo, P | 1 |
| Uncini, A | 1 |
| Servidei, S | 1 |
| Roti, E | 4 |
| Gardini, E | 4 |
| Minelli, R | 1 |
| Bianconi, L | 1 |
| Salvi, M | 4 |
| Gavaruzzi, G | 1 |
| Braverman, LE | 4 |
| Bazzi, MN | 1 |
| Bagchi, N | 1 |
| Croxson, MS | 1 |
| Hall, TD | 1 |
| Nicoloff, JT | 2 |
| Izumi, M | 1 |
| Larsen, PR | 1 |
| Labhart, A | 1 |
| Barnes, ND | 1 |
| O'Connell, EJ | 1 |
| Cloutier, MD | 1 |
| Wood, LC | 1 |
| Philippou, G | 1 |
| Piperingos, G | 1 |
| Souvatzoglou, A | 1 |
| Koutras, DA | 1 |
| Moulopoulos, SD | 1 |
| Wilson, R | 2 |
| McKillop, JH | 2 |
| Thomson, JA | 2 |
| DeGroot, LJ | 2 |
| Mangklabruks, A | 1 |
| McCormick, M | 1 |
| Robuschi, G | 3 |
| Montermini, M | 3 |
| Manfredi, A | 3 |
| Gnudi, A | 3 |
| Pearson, C | 1 |
| Burnett, AK | 1 |
| Gunn, I | 1 |
| McNicol, AM | 1 |
| d'Amato, L | 2 |
| Borciani, E | 1 |
| Negrotti, L | 1 |
| Hiyama, Y | 1 |
| Hosoya, T | 1 |
| Tarutani, O | 1 |
| Barlli, AL | 1 |
| Doménech, E | 1 |
| Santisteban, M | 1 |
| Moya, M | 1 |
| González, C | 1 |
| Cortabarría, C | 1 |
| Méndez, A | 1 |
| Alvarez, J | 1 |
| Rodríguez-Luis, JC | 1 |
| Peden, NR | 1 |
| Browning, MC | 1 |
| Forrest, AL | 1 |
| Gunn, A | 1 |
| Hamilton, WF | 1 |
| Isles, TE | 1 |
| Singer, PA | 1 |
| Altman, RP | 1 |
| Cevallos, JL | 1 |
| Hagen, GA | 1 |
| Chapman, EM | 1 |
| Woeber, KA | 1 |
| Ingbar, SH | 1 |
| Ivy, HK | 1 |
| Wahner, HW | 1 |
| Gorman, CA | 1 |
| Rolland, M | 1 |
| Montfort, MF | 1 |
| Valenta, L | 1 |
| Lissitzky, S | 1 |
| Ayromlooi, J | 1 |
| Sebaoun, J | 1 |
| Delzant, G | 1 |
| Peillon, F | 1 |
| Amiel, C | 1 |
| Minkowski, A | 1 |
| Lacome, M | 1 |
| Dahl, IL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter[NCT04856488] | Phase 3 | 182 participants (Anticipated) | Interventional | 2021-11-18 | Recruiting | ||
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| he Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial[NCT06068179] | Phase 2/Phase 3 | 205 participants (Anticipated) | Interventional | 2023-10-08 | Not yet recruiting | ||
| Clinical and Surgical Outcomes of Total Thyroidectomy in Basedow's Disease: the Effect of Lugol Solution[NCT05784792] | 50 participants (Anticipated) | Interventional | 2020-02-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for potassium iodide and Basedow Disease
| Article | Year |
|---|---|
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
6 trials available for potassium iodide and Basedow Disease
| Article | Year |
|---|---|
Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Potas | 2020 |
Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Drug Administration Schedule; Drug Therapy, Comb | 2015 |
Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease.
Topics: Adult; Blood Loss, Surgical; Female; Graves Disease; Humans; Male; Operative Time; Potassium Iodide; | 2017 |
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Topics: Adult; Antithyroid Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Graves D | 2010 |
Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
Topics: Adult; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Female; Graves Disease; Heart Rat | 1988 |
Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
Topics: Adult; Clinical Trials as Topic; Female; Graves Disease; Humans; Ipodate; Male; Middle Aged; Potassi | 1986 |
63 other studies available for potassium iodide and Basedow Disease
| Article | Year |
|---|---|
Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodides; Iodine Radiois | 2022 |
Asymmetrical Graves' disease in children: potential usefulness of potassium iodide monotherapy.
Topics: Autoantibodies; Child; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Potassium | 2022 |
Painless thyroiditis mimicking relapse of hyperthyroidism during or after potassium iodide or thionamide therapy for Graves' disease resulting in remission.
Topics: Antithyroid Agents; Autoantibodies; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunog | 2023 |
Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
Topics: Female; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Methimazole; Potassium Iodide | 2023 |
Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
Topics: Ankle; Anorexia; Antithyroid Agents; Aromatase Inhibitors; Arthralgia; Bone Density Conservation Age | 2020 |
Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
Topics: Adult; Antithyroid Agents; Drug Substitution; Female; Graves Disease; Humans; Methimazole; Potassium | 2020 |
A 62-Year-Old Woman With Diffuse Myalgias, Fatigue, and Shortness of Breath.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Anticoagulants; Antithyroid Agents; Atrial Fibrill | 2020 |
Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antithyroid Agents; | 2020 |
Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Female; Graves Disease; Humans; | 2020 |
Influence of Short-Term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease.
Topics: Adult; Antithyroid Agents; Diet; Drug Administration Schedule; Female; Graves Disease; Humans; Iodin | 2021 |
New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report.
Topics: Adenocarcinoma; Aged; Graves Disease; Humans; Japan; Male; Methimazole; Nivolumab; Potassium Iodide; | 2020 |
Clinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease Patients.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Potassium Iodide; Thyroid | 2021 |
Effect of preoperative potassium iodide administration on Graves' disease surgery: a propensity score analysis.
Topics: Female; Graves Disease; Humans; Male; Middle Aged; Potassium Iodide; Preoperative Care; Propensity S | 2021 |
Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Infant, Newborn; Male; Maternal-F | 2021 |
Editorial: The use of potassium iodide in Graves' disease.
Topics: Graves Disease; Humans; Potassium Iodide; Propranolol | 2018 |
Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Postoperative Complications; Potassium Iod | 2018 |
RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged | 2017 |
Impact of potassium iodide on thyroidectomy for Graves' disease: implications for safety and operative difficulty.
Topics: Graves Disease; Humans; Postoperative Complications; Potassium Iodide; Thyroidectomy | 2019 |
Is potassium iodide solution necessary before total thyroidectomy for Graves disease?
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; Humans | 2013 |
Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy.
Topics: Ablation Techniques; Adult; Antithyroid Agents; Combined Modality Therapy; Dietary Supplements; Fema | 2013 |
Thyroidectomy in a patient with thyroid storm: report of a case.
Topics: Adult; Antithyroid Agents; Betamethasone; Combined Modality Therapy; Contraindications; Digoxin; Diu | 2015 |
Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring.
Topics: Antithyroid Agents; Blood Glucose; Delayed Diagnosis; Diabetes Mellitus, Type 2; Drug Monitoring; Dr | 2014 |
Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Pot | 2014 |
Images in clinical medicine. Neonatal thyrotoxicosis.
Topics: Adult; Apgar Score; Eyelids; Female; Fetal Growth Retardation; Graves Disease; Heart Rate, Fetal; Hu | 2014 |
Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; H | 2014 |
[Rare, severe hypersensitivity reaction to potassium iodide].
Topics: Drug Eruptions; Female; Graves Disease; Humans; Middle Aged; Potassium Iodide; Thyrotoxicosis | 2014 |
Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Topics: Abnormalities, Drug-Induced; Adult; Antithyroid Agents; Drug Substitution; Female; Graves Disease; H | 2015 |
Comment on article entitled "Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease".
Topics: Graves Disease; Humans; Potassium Iodide; Thyroidectomy | 2017 |
Preoperative administration of excess iodide increases thyroid volume of patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Male; Potassium Iodide; Preoperative Care; Retrospective Stud | 2009 |
Optimizing remission rates using antithyroid drugs for Graves' disease.
Topics: Antithyroid Agents; Calibration; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug T | 2010 |
Thyroid storm after coronary artery bypass grafting.
Topics: Antithyroid Agents; Coronary Artery Bypass; Coronary Stenosis; Drug Therapy, Combination; Female; Gr | 2010 |
Acid protease activity in thyroid gland from patients with Graves' disease.
Topics: Animals; Aspartic Acid Endopeptidases; Endopeptidases; Graves Disease; Humans; Hydrolysis; In Vitro | 1983 |
[Surgical treatment of Basedow's disease. I--Traditions and new methods in preparation for thyroidectomy: use of dexamethasone].
Topics: Adult; Carbimazole; Dexamethasone; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; | 1984 |
Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotop | 1983 |
Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Potassium Iodide; Preoperative Car | 1980 |
Potassium iodide and propranolol in Graves' disease.
Topics: Graves Disease; Humans; Potassium Iodide; Propranolol | 1980 |
Potassium iodide and propranolol in Graves' disease.
Topics: Drug Therapy, Combination; Graves Disease; Humans; Potassium Iodide; Propranolol | 1980 |
[Clinical study of a case of recurrent multineuritis of the oculomotor nerves in a patient with secondary hypothyroidism].
Topics: Adult; Graves Disease; Humans; Hypothyroidism; Male; Neuritis; Oculomotor Nerve; Ophthalmoplegia; Po | 1981 |
Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Methimazole; Middle Aged; Potassium Iodide; Refe | 1993 |
Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Graves Disease; Humans; Iodine Ra | 1993 |
Combination drug therapy for treatment of hyperthyroid Grave's disease.
Topics: Adult; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1977 |
Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
Topics: Child, Preschool; Female; Graves Disease; Humans; Potassium Iodide; Propylthiouracil; Thyroglobulin; | 1978 |
[Differential diagnosis and treatment of the goitre (author's transl)].
Topics: Diagnosis, Differential; Goiter; Graves Disease; Humans; Potassium Iodide; Thyroiditis, Autoimmune; | 1978 |
Iodide-induced (SSKI) hypothyroidism in infancy.
Topics: Adult; Asthma; Female; Graves Disease; Humans; Hypothyroidism; Infant; Male; Potassium Iodide; Propy | 1975 |
Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
Topics: Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Middle Aged; Postope | 1975 |
Treatment of hyperthyroidism with potassium iodide.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Potassium Iodide; Thyrotropin; Thyroxi | 1991 |
The effect of pre-operative potassium iodide therapy on antibody production.
Topics: Antibody Formation; Autoantibodies; B-Lymphocytes; Carbimazole; Enzyme-Linked Immunosorbent Assay; F | 1990 |
Comparison of RA 131I treatment protocols for Graves' disease.
Topics: Combined Modality Therapy; Eye Diseases; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radi | 1990 |
Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
Topics: Autoantibodies; Carbimazole; Drug Therapy, Combination; Graves Disease; Humans; Potassium Iodide; Pr | 1988 |
[Peroxidase activity of thyroid tissue in toxic diffuse goiter. Difference among thyroids administered antithyroid drugs and potassium iodide].
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Peroxidases; Pota | 1986 |
Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Ipodate; Male; Potassium Iodide; Thyroid Hormones; Thyroxine; | 1985 |
[Transient neonatal hyperthyroidism in the child of a treated hyperthyroid mother. Subsequent appearance of sexual precocity].
Topics: Carbimazole; Female; Fibrous Dysplasia, Polyostotic; Graves Disease; Humans; Hyperthyroidism; Infant | 1985 |
The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens.
Topics: Adult; Body Temperature; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; Nadolol; P | 1985 |
Metabolic clearance rates of diiodotyrosine in man.
Topics: Adult; Chromatography, Paper; Depression, Chemical; Diiodotyrosine; Female; Goiter, Nodular; Graves | 1972 |
Action of potassium iodide on thyroxine metabolism.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Potassium Iodide; Thyr | 1966 |
Total thyroidectomy for the treatment of Graves' disease in children.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypocalcemia; Laryngeal Edema; M | 1973 |
Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
Topics: Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Potassium Iodide; R | 1974 |
Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter.
Topics: Cholesterol; Female; Graves Disease; Humans; Hypothyroidism; Iodides; Iodine Isotopes; Male; Myxedem | 1969 |
"Triiodothyronine (T 3 ) toxicosis". Its role in Graves' disease.
Topics: Adult; Aged; Basal Metabolism; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Mid | 1971 |
Iodoamino acid composition of the thyroglobulin of normal and diseased thyroid glands. Comparison with in vitro iodinated thyroglobulin.
Topics: Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Diiodotyrosine; Goiter; Graves Disease; | 1972 |
Congenital goiter due to maternal ingestion of iodides.
Topics: Apgar Score; Bone Diseases, Developmental; Cesarean Section; Electroencephalography; Female; Fetus; | 1972 |
[Study of a case of neonatal thyrotoxicosis in an infant born of a mother with Basedow's disease].
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Infant, Premature, Diseases | 1967 |
Thyroid crisis in a 3-year-old girl.
Topics: Child; Child, Preschool; Female; Glucose; Graves Disease; Humans; Iodine; Potassium Iodide; Thyroid | 1968 |